Uveal melanoma
Uveal Melanoma is a rare form of eye cancer that originates in the uvea, the middle layer of the eye that includes the iris, ciliary body, and choroid. It is the most common primary intraocular malignancy in adults, but it is still relatively rare compared to other types of cancer.
Etiology
The exact cause of uveal melanoma is not known. However, certain risk factors have been identified, including light eye color, older age, and certain genetic mutations. Exposure to sunlight or artificial UV light does not appear to be a risk factor, unlike cutaneous melanoma.
Pathophysiology
Uveal melanoma arises from melanocytes, the pigment-producing cells in the uvea. These cells can undergo genetic mutations that cause them to grow and divide uncontrollably, forming a tumor. The most common genetic mutations in uveal melanoma involve the GNAQ and GNA11 genes.
Clinical Presentation
Patients with uveal melanoma may be asymptomatic, or they may present with visual disturbances such as blurred vision or a dark spot in the visual field. On examination, a pigmented lesion may be seen in the eye.
Diagnosis
The diagnosis of uveal melanoma is typically made based on clinical examination and imaging studies, such as ultrasound of the eye. A biopsy may be performed in some cases to confirm the diagnosis and assess for genetic mutations.
Treatment
The treatment of uveal melanoma depends on the size and location of the tumor, as well as the patient's overall health. Treatment options may include surgery, radiation therapy, and targeted therapy with drugs that attack specific genetic mutations.
Prognosis
The prognosis of uveal melanoma depends on various factors, including the size and location of the tumor, the presence of genetic mutations, and whether the cancer has spread to other parts of the body.
See Also
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

